LOXL2-dependent deacetylation of aldolase A induces metabolic reprogramming and tumor progression
J.-W. Jiao, X.-H. Zhan, J.-J. Wang, L.-X. He, Z.-C. Guo, X.-E. Xu, L.-D. Liao, X. Huang, B. Wen, Y.-W. Xu, H. Hu, G. Neufeld, Z.-J. Chang, K. Zhang, L.-Y. Xu, E.-M. Li
This study identifies LOXL2 and its variant L2{Delta}13 as deacetylases that reprogram tumor metabolism by deacetylating aldolase A, promoting tumor progression.
bioRxiv · Mar 6, 2022Cell Biology